Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Lupin
Lupin
BSE: 500257NSE: LUPINISIN: INE326A01037

14th-Oct-2019 16:26Source: BSE

Lupin - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0440
Name of the Signatory :- Pradeep Bhagwat
Designation :- Authorised Signatory

Sections
Follow us on
Available On